Redeye revises its estimates on the back of the Q3 2023 report, which came in below our expectations in terms of both sales and profitability. While the Q3 figures fell below our expectations, SDS continues substituting low-margin sales from SDD with recurring revenues.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Seamless Distribution Systems - Soft quarter but improvements under the surface

© Modular Finance, source Nordic Press Releases